1. Mitotic Arrest-Deficient 2 Like 2 (MAD2L2) Interacts with Escherichia coli Effector Protein EspF
   Amin Tahoun et al, 2021, Life CrossRef
2. REV7 in Cancer Biology and Management
   Yoshiki Murakumo et al, 2023, Cancers CrossRef
3. Anti-Cancer Mechanisms of Diarylpentanoid MS17 (1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one) in Human Colon Cancer Cells: A Proteomics Approach
   Kha Wai Hon et al, 2024, International Journal of Molecular Sciences CrossRef
4. REV7 is involved in outcomes of platinum‐based chemotherapy in pancreatic cancer by controlling the DNA damage response
   Akihiro Tamaki et al, 2024, Cancer Science CrossRef
5. Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches
   Fakhria Al-Joufi et al, 2022, Nanomaterials CrossRef
6. Ototoxicity among cisplatin, carboplatin, and oxaliplatin in zebrafish model
   Kuan‐Hui Li et al, 2024, Environmental Toxicology CrossRef
7. The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma
   Zhiyuan Liu et al, 2023, Journal of Translational Medicine CrossRef
8. Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer
   Chunlin Lin et al, 2024, Cancer Letters CrossRef